Schrödinger, Inc. provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications.The Software segment is focused on selling its software for drug discovery in the life sciences industry. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations.
